Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies.

Cancers (Basel) · 2020 · PMC7761123 · PMID 33256106

Europe PMC DOI

hedged sentence

0.1783

closest p · 3.6× alpha

0.1783

boldest claim

The sentences

showed a trendp = 0.1783not close (p > 0.1)

Finally, animals treated with both Bev and βPix/COOL-1 siRNA-loaded RGD-NP showed a trend towards increased survival ( p = 0.1783), having an improved median survival of 100 days when compared with other treatment groups. 3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.